Last reviewed · How we verify
NCT05779384: COPA
The COPD Attack Study
trial testing It was an observational study in Pulmonary Disease, Chronic Obstructive in 323 participants. Completed in 30 March 2021.
30 March 2021
Quick facts
| Lead sponsor | Makerere University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 323 |
| Start date | 7 July 2019 |
| Primary completion | 30 March 2021 |
| Estimated completion | 30 March 2021 |
| Sites | 2 locations across Uganda |
Drugs / interventions tested
- It was an observational study
Conditions studied
- Pulmonary Disease, Chronic Obstructive — all drugs for Pulmonary Disease, Chronic Obstructive →
- Exacerbation COPD — all drugs for Exacerbation COPD →
Sponsor
Makerere University
Who can join
Adults 30 to 100, any sex, with Pulmonary Disease, Chronic Obstructive or Exacerbation COPD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to evaluate the frequency and predictors of exacerbations in COPD patient population in Uganda. The main questions it aims to answer are:- 1. What is the proportion of frequent exacerbators (≥2/year) and what factors are associated with the frequent exacerbator phenotype? 2. What is the frequency of exacerbations and what factors are correlated with exacerbation frequency? Participants will be asked to offer demographic ,clinical and exposure questions. Questionnaires assessing disease burden, and quality of life will be administered. Clinical measurements, and complete blood count will be collected ta baseline and on sick visits. Spirometry will be measured at baseline and on the last visit. Samples will be collected for storage. Participants will be followed up for one year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05779384
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Disease, Chronic Obstructive
Currently open trials in the same condition.
- NCT07177339 — eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO · Phase 3 · recruiting
- NCT06961214 — Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T · Phase 3 · recruiting
- NCT06959095 — Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T · Phase 3 · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT06712563 — Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting · recruiting
Other Makerere University trials
Trials by the same sponsor.
- NCT07407868 — Call for Life Sepsis · NA · not yet recruiting
- NCT06975670 — Enhancing Comprehension of Consent in Patients With Psychotic Disorders · NA · not yet recruiting
- NCT06139198 — Self-management Intervention for Reducing Epilepsy Burden Among Ugandans With Epilepsy. · NA · recruiting
- NCT06791928 — Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services · Phase 2 · enrolling by invitation
- NCT06563440 — Development and Evaluation of an Information Management System and Communication System for Population-wide Point-of-car · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05779384 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Makerere University
- Last refreshed: 22 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05779384.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing